The person is Grace Wade.

A woman drawing insulin from a syringe

Depending on the type of insurance a person has, the cost of insufficiencies can vary.

Clynt Garnham Medical is located in Alamy.

More than one million people with diabetes in the US have to ration their blood sugar levels due to high costs.

Drug manufacturers in the US charge more for a standard unit of insulin than they do in Canada or the UK. Depending on their health insurance, some people in the US pay nothing for diabetes care, while others pay full price.

Adam Gaffney and his colleagues at Cambridge Health Alliance looked at the data from the National Health Interview Survey to find out how the costs affect the use of diabetes drugs. The US Centers for Disease Control and Prevention surveys adults from a sample of US households to collect data on income, health status, insurance coverage and more.

For the first time in the history of the survey, people with diabetes were asked if they had skipped or taken lessinsulin than needed to save money. More than 15% of the group answered yes to at least one of the questions. The CDC designed the survey to be nationally representative, so Gaffney and the team were able to estimate the number of people with diabetes who don't use the drug.

Something very troubling about the state of our healthcare system was said by Gaffney. Many people with diabetes can't control their blood sugar levels because they don't have the drug.

The people without health insurance had the highest rate of rationing. Nineteen per cent of people with private health insurance rationed diabetes, compared to sixteen per cent of people with Medicare. Some private insurance plans have high out-of-pocket costs.

People who were Black, under the age of 65, and considered low-to-middle income were more likely to use the drug. Andrew Mulcahy at the RAND corporation in Washington DC says that these demographic are already facing higherinsulin costs because of healthcare disparity.

Read more: Is covid-19 causing a global surge of diabetes cases?

The Inflation Reduction Act that was passed earlier this year capped the cost of diabetes care for Medicare recipients at $35 a month. The cap for people with private insurance was removed during negotiations.

The Medicare population is already doing well on this measure, so I don't think it will change anything. To address the root issue, you need to think about getting patients with private coverage and patients without any coverage at all.

The Annals of Internal Medicine has a journal title.

There are more on this topic.